Table of Contents
Introduction
Renal failure is often linked to ischemic stroke, and approximately one-third of patients hospitalized for intracerebral hemorrhage (ICH) have chronic kidney disease (CKD). Important management issues that are currently underrepresented in the literature include the severity of the impairment and the need for renal replacement therapy for these patients during their treatment. It is commonly recognized that receiving proper general medical care can significantly improve a stroke patient's prognosis. Apart from the noteworthy mortality and morbidity linked to cerebrovascular accidents, chronic kidney disease (CKD) is a dependable predictor of unfavorable clinical outcomes and death after a primary stroke. When compared to the general population, people with chronic kidney disease (CKD) have been shown to have worse outcomes when dangerous conditions co-occur.
These conditions include anemia, oxidative stress, platelet dysfunction, electrolyte imbalance, and hyperhomocysteinemia. Furthermore, the chance of having another ischemic or hemorrhagic stroke is increased by even milder stages of CKD. A drop in e-GFR of less than 40 mL/min signifies a 3.1-fold increase in the general population's chance of experiencing a symptomatic stroke. Therefore, to enhance the prognosis of hospitalized patients with cerebrovascular accidents, it is imperative to provide appropriate and regular examinations of renal function.
How Renal Disease and Cerebral Autoregulation Are Related?
The microvasculature and vasoregulation of the kidney and brain are comparable, making them susceptible to microvascular malfunction. "Low resistance" arterial networks, which allow for continuous high-volume blood flow during both systole and diastole, perfuse both organs. Small vessels in other organs are protected by upstream vasoconstriction. Still, small arteries in the brain and kidney are constantly subject to variations in pressure and flow due to low vascular resistance and upstream vasodilation. The brain vasculature exhibits cerebral autoregulation to decrease hypoperfusion in low blood pressure and hyperperfusion during high blood pressure situations, maintaining relatively constant blood flow to the brain despite varying systemic blood pressures.
Brain autoregulation is an intricate intrinsic regulatory system that modifies brain activity to maintain a consistent CBF. A sophisticated intrinsic control system called cerebral autoregulation adjusts cerebral vascular resistance in response to variations in blood pressure, cerebral perfusion pressure, or metabolic demands to maintain a steady cerebral blood flow. An intact blood–brain barrier and sustained endothelial function are necessary for intact cerebral autoregulation.
Brain autoregulation is less efficient in those with a lower eGFR. Poorer autoregulation was linked to decreased eGFR and a higher likelihood of hemorrhagic transformation of ischemic stroke, according to a prospective analysis of patients who had experienced an acute ischemic stroke. In the context of compromised autoregulation, breakthrough hyperperfusion and microvascular damage may lead to hemorrhagic transformation. According to this study, the likelihood of a successful functional outcome following a stroke decreased when reduced eGFR and poor autoregulation were combined.
How Renal Dysfunction Effects on Ischemic Stroke?
Patients with chronic kidney disease (CKD) and end-stage renal disease have a markedly increased risk of stroke and post-stroke mortality. Severe neurological impairments and increased in-hospital mortality following stroke are linked to proteinuria. One of the main causes of death for CKD patients is hemorrhagic stroke. Individuals with chronic kidney disease (CKD) have a 5 to 30 times higher risk of atherosclerotic cardiovascular illnesses, including myocardial infarction and stroke. This risk is also higher in individuals receiving dialysis. Individuals with End-Stage Renal illness who get hemodialysis or peritoneal dialysis are at a heightened risk of stroke, particularly hemorrhagic stroke in hemodialysis patients. The risk of de novo stroke, stroke severity, and stroke-related mortality was found to be significantly higher among AKI patients who recovered following dialysis treatment (regardless of subsequent progression to CKD) compared to the non-AKI group in a large-scale study involving 4315 patients over an average follow-up period of 3.36 years. The abrupt drop in systemic blood pressure that occurs during dialysis may contribute, at least in part, to the decreased brain perfusion that puts patients with kidney disease at higher risk of stroke. On the other hand, cerebral harm brought on by renal failure might also be caused by other causes.
Comparing mice with severe ischemic AKI to sham control mice, the former exhibit increased proinflammatory chemokine expression in the brain, increased neuronal pyknosis, induced microgliosis and astrogliosis, disruption of the blood-brain barrier (BBB), and impaired locomotor activity. Comorbidity with ischemic stroke exacerbates neurological impairments, increases infarct volume, and greatly enhances inflammatory responses in CKD mice. These responses include increased production of inflammatory cytokines and M1 microglia/macrophages in the ischemic brain.
Stroke in CKD patients may be caused by chronic inflammation, elevated oxidative stress, reduced nitric oxide generation, endothelial dysfunction, platelet aggregation, and vascular damage. A recent analysis examined the processes that lead to worse stroke outcomes and exacerbated stroke etiology in individuals with chronic kidney disease. Comorbid conditions like hypertension may contribute to CKD patients' higher risk of stroke.
Hypertension:
It is well-recognized that hypertension exacerbates the risk of stroke and its consequences. Kidney failure can have two possible outcomes:
-
Elevated blood pressure that persists over time accelerates renal impairment.
Both can be a cause and an effect of renal dysfunction. Both sympathetic activation and heightened renin, angiotensin, and aldosterone system activity can lead to hypertension. Hypertension can impair cerebral autoregulation and cause stroke by increasing arterial stiffness, endothelial dysfunction, and vascular shear stress.
In addition to developing spontaneous brain lesions, animals exposed to a renovascular model of chronic arterial hypertension also developed more significant brain lesions when they experienced ischemia. For CKD patients, blood pressure control may be a crucial treatment approach for preventing both main and secondary strokes.
Conclusion
The above-mentioned elevated risks of atrial fibrillation and other etiologies of cardioembolic stroke may be more strongly connected with CKD, even though it may be associated with cerebral big artery disease through arterial medial calcification and stiffening of large arteries. It should be remembered that the focus of this study was on the prevalence of each ischemic stroke subtype in individuals with renal impairment, not their frequency. Previous research has also shown that there is no correlation between the proportion of big vascular stroke in cohorts as a whole and renal impairment. Due to the underlying heterogeneity of stroke causation, no correlation between renal function and other specified stroke etiology may be found. Furthermore, significant correlations between renal impairment and mortality and recurrence following an embolic stroke of unknown cause were refuted by the most current pooled data.
